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A B S T R A C T   
Although the interest towards functional food has dramatically increased, several factors jeopardize their 
effective development. A univocally recognized definition and a dedicated regulation for this emerging food 
category is lacking, and a gap exists between the technological and the nutritional viewpoints. Involved actors 
speak different languages, thus impinging the progression towards an integrated approach for functional food 
development. 
A holistic approach to rationalize functional food development was here proposed, i.e., the “Functional Food 
Development Cycle”. First regulation and definitions were reviewed. The technological approaches for functional 
food design were then described, followed by the efficacy evaluation ones. Merging the technological and the 
evaluation viewpoints, by identifying the best compromise between quality and functionality, is pivotal to 
develop effective functional foods. Finally, delivering functional food on the market requires dedicated 
communication strategies. These in turn can provide information about consumer needs, thus representing an 
input for regulatory bodies to drive the development of functional food, feeding it within an iterative and 
virtuous holistic cycle.   
1. Historical overview of functional food 
The term “functional food” firstly appeared in Japan in 1984. The 
Japanese government defined a new product category, Food for Specific 
Health Uses (FOSHU), as “food containing an ingredient with functions 
for health and officially approved to claim their physiological effects on 
the human body” and produced a dedicated legislative framework. 
Japan was followed by the United States that in the ’90s developed the 
first health claim act, but without providing a formal definition of 
functional food (Martirosyan & Singh, 2015). European countries ac-
quired the functional food concept more than 10 years later when the 
European Parliament and Council introduced the regulation on nutri-
tional and health claims (Reg. (EU) n. 1924/2006); but also in this case 
no formal definition was mentioned. 
The research interest towards functional food experienced a steep 
increase only in the 21st century (Fig. 1a) and this globally growing 
attention has tremendously influenced their market (Kaur & Das, 2011), 
the size of which was estimated at USD 162 billion in 2018 and was 
projected to reach USD 280 billion by 2025 with an annual growth rate 
of around 8% (Grand View Research, 2019b, 2019a). 
2. Functional food issues 
2.1. Definition: What are we talking about? 
Although the research interest and the market of functional food are 
exponentially growing, many stakeholders in the European Union are 
disoriented, due to the lack of a comprehensive picture on this topic, 
which jeopardizes their effective development. This has produced a 
debate on the functional food definition that has been ongoing for more 
than 20 years and is still opened. The term “functional food” generally 
refers to products providing a specific health benefit, beyond basic 
nutrition. Although different terms in the field of food providing health 
benefits have been univocally defined by EU and extra-EU legislation, as 
in the case of food supplements and food for medical use, still no com-
mon and exhaustive definition has been recognized for functional food 
yet (Table 1). Actually, the terms nutraceutical and functional foods are 
often confused and interchanged. 
Different attempts have been made to propose a commonly agreed 
definition. The last proposal was that presented by the Functional Food 
Center (FFC) in 2018 (Table 1), describing functional foods as “natural 
or processed foods that contain biologically active compounds; which, in 
defined, effective, and non-toxic amounts, provide a clinically proven 
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and documented health benefit utilizing specific biomarkers for the 
prevention, management, or treatment of a chronic disease or its 
symptoms” (Gur, Mawuntu, & Martirosyan, 2018). 
Based on this definition, a conventional product (“natural or pro-
cessed food”) containing components positively affecting health should 
be regarded as a functional food as well (Gur et al., 2018). However, 
such a definition is not fully accepted, as other authors excluded from 
the functional food category those products naturally containing 
bioactive compounds (Kaur & Das, 2011). In particular, they stated that 
foods can be defined as functional only if belonging to the following 
classes:  
• products fortified with ingredients having a positive health 
influence;  
• products cleared from anti-nutritional compounds;  
• raw materials improved/fortified/cleared by changing agricultural 
practices (i.e., animal feeding and vegetable breeding) or postharvest 
treatments (fruits and vegetables);  
• novel foods with an improved health benefit. 
On the other hand, the definition by Gur et al. (2018) does not 
include those products cleared from some components (i.e., light foods), 
although these are generally intended as foods carrying a health- 
promoting effect. 
As a result, when dealing with functional food there is a high risk of 
confusion and misunderstanding, and this term is currently used mostly 
as a marketing idiom (Martirosyan & Singh, 2015), pointing out the 
urgent need for a standard functional food definition approved by 
governments. 
In fact, the absence of an agreed definition brings about the lack of a 
dedicated legislative framework in Europe. Currently, several regula-
tions relevant to the food field apply to this category. However, a 
dedicated regulation establishing functional food as a separate category 
is urgently needed (Gur et al., 2018) to guide and control the innovation 
in the functional food field by setting rules and standards (Moors, 2012). 
These are essential to reduce the fear of working in a grey area and 
increasing the investments in functional food R&D (Kaur & Das, 2011). 
Another key aspect to be considered is the need for rules to assess 
functional food efficacy. This issue has already been brought about by 
the Reg. (EU) n. 1924/2006 concerning nutritional and health claims, 
and more in detail by the Reg. (EU) n. 353/2008 that establishes the 
requirements for health claims to be authorized. These cover a broad 
range of effects, including immune system protection, prevention of 
oxidative damage and cardiovascular diseases, control of blood glucose 
levels, the health of bones and skin, protection of nervous system, and 
overall improvement of physical performances. However, demon-
strating such effects is challenging and claims are often rejected by 
EFSA. In fact, food matrix complexity hinders making clear cause-effect 
Fig. 1. Number of papers published between 1985 and 2019 containing the keywords “functional food” (a), or the keywords “functional food” associated with 
“unconventional processing”, “conventional processing” or “formulation” (b). 
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relationships, disguising the observed effects, and leading to outcome 
misinterpretation. 
2.2. Design: Approaches to deliver functional food 
Although many proposals have been made for a common approach to 
deliver effective functional food, based on a rational design from the 
molecular to the macroscopic level (McClements, 2009), the lack of a 
defined target hinders their implementation (Gur et al., 2018). 
The first step to develop a functional food is to identify a goal. This 
can be selected based on two opposite paths: one can be regarded as a 
top-down approach, deriving from a new idea to face food-related health 
issues. Although the innovative potential, this approach does not result 
in an adequate involvement of all the actors and might not fulfill con-
sumer expectations. Thus, more favorably a bottom-up approach should 
be applied, to deliver effective solutions to food-related health issues, 
while guaranteeing consumer acceptability (Bigliardi & Galati, 2013; 
Bleiel, 2010; Gur et al., 2018; Jones & Jew, 2007; Siró, Kápolna, 
Kápolna, & Lugasi, 2008). 
In industrialized countries, because of rising medical costs and 
increased life span, nutritional recommendations formulated by health 
professionals have motivated the food industry to provide products that 
help consumers to be in line with these recommendations (Kaur & Das, 
2011). Considering the most incident health-related chronic diseases (i. 
e., obesity, CVD, and diabetes), two are the major targets to be achieved 
through food design, i.e., reducing the energy intake and introducing 
food with healthy properties (Table 2). 
To reduce the energy intake, it is necessary decreasing the intake of 
macronutrients or slowing down their digestion thus maintaining con-
stant their concentration in the bloodstream (Table 2). This, in turn, 
would contribute to increasing the satiety feeling, playing an indirect 
effect on the energy intake (Ruijschop, Burseg, Lambers, & Overduin, 
2009). On the other hand, introducing food with healthy properties 
implies delivering micronutrients that play an active role in the pre-
vention and management of diet-related chronic diseases. 
These targets can be gathered through different tactics including 
simple dietary approaches, as well as technological interventions, 
intended as formulation or processing (Table 2). 
2.2.1. Diet 
The first crucial aspect to be considered when dealing with food 
functionality is the co-ingestion with other foods within a meal and/or 
with the drugs used to treat chronic diseases (Koziolek et al., 2019). 
Food-drug interactions are mostly examined from the side-effect view-
point, instead of considering the possible beneficial outcomes. However, 
some studies highlighted the possibility to take advantage of these in-
teractions. Table 3 reports some examples of positive food-drug in-
teractions, considering the compounds under investigation, the food 
Table 1 
Definitions of functional food and nutraceutical, and relevant references.  
Term Definition Reference 
Functional 
food 
Foods that encompass potentially 
healthful products, including any 
modified foods or food ingredients 
that may provide a health benefit 
beyond the nutrients it contains 
Thomas and Earl (1994)  
Product which is shown in a 
satisfactory manner that, in addition 
to adequate nutritional effects, 
induces beneficial effects on one or 
more target functions of the organism, 
significantly improving the health 
status and welfare or reducing the risk 
of disease 
Diplock et al. (1999)  
Nutrient consumed as part of a normal 
diet but delivering one or more active 
ingredients (that have physiological 
effects and may enhance health) 
within the food matrix 
Zeisel (1999)  
Any food or ingredient that has a 
positive impact on an individual’s 
health, physical performance, or state 
of mind, in addition to its nutritive 
value 
Hardy (2000)  
Foods and food components that 
provide a health benefit beyond basic 
nutrition. These substances provide 
essential nutrients often beyond 
quantities necessary for normal 
maintenance, growth, and 
development, and/or other 
biologically active components that 
impact health benefits 
IFT (2005)  
Foods that may provide a health 
benefit beyond basic nutrition 
Day, Seymour, Pitts, 
Konczak, and Lundin 
(2009)  
Natural or processed foods that 
contain known or unknown 
biologically active compounds; which, 
in defined, effective, and non-toxic 
amounts, provide a clinically proven 
and documented health benefit for the 
prevention, management, or 
treatment of chronic diseases 
Martirosyan and Prasad 
(2009)  
Natural or processed foods that 
contain biologically active 
compounds; which, in defined, 
effective, and non-toxic amounts, 
provide a clinically proven and 
documented health benefit utilizing 
specific biomarkers for the prevention, 
management, or treatment of chronic 
disease or its symptoms 
Gur et al. (2018) 
Nutraceutical Food or part of food that provides 
medical or health benefits, including 
the prevention and/or treatment of a 
disease 
De Felice (1995)  
Any substance that is a food or a part 
of a food and is able to induce medical 
and health benefits, including the 
prevention and treatment of disease 
Brower (1998)  
A diet supplement that delivers a 
concentrated form of a biologically 
active component of food in a nonfood 
matrix to enhance health 
Zeisel (1999)  
A foodstuff (as a fortified food or 
dietary supplement) that provides 





Nutritional products that provide 
health and medical benefits, including 
the prevention and treatment of 
disease 
Santini et al. (2018)  
Table 2 
Target, strategy, and tactic to be implemented to design functional food.  




macronutrient intake  
• slowing down 
macronutrient digestion  
• increasing the satiety 
feeling  
• using naturally low energy 
food  
• reducing conventional food 
portions  
• formulating low energy 
food  
• designing food structures 







and absorption  
• using food naturally 
providing bioactive 
compounds  
• formulating food enriched/ 
fortified with bioactive 
compounds  
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Table 3 
Examples of different approaches towards non-communicable diseases prevention and/or management, food matrix and treatment, bioactive compounds involved, 
effect on physiological functions (↑: increased/improved; ↓: decreased), and relevant references.  






Green tea Catechins – antihypertensives (diltazem, nicardipine, 
verapamil) 
Catechins – cardiovascular drugs (verapamil, nadolol) 
Catechins – anti-hypercholesterolemic drugs 
(simvastatin) 
Catechins – chemotherapics (tamoxifen, 5-fluoro-
uracil, sunitinib) 
Catechins - antipsychotics (quetiapine, clozapine) 
↑ Cardiovascular 
functionality 




Albassam and Markowitz (2017)  
Coffee Caffeine – cardiovascular drugs (lidocaine, mexiletine, 
propafenone, propranolol, triamterene, verapamil, 
warfarin) 
Caffeine – anti-inflammatory drugs (methotrexate) 
Caffeine – antipsychotics (clozapine, haloperidol, 
olanzapine) 
Caffeine – antidepressants (amitriptyline, 
clomipramine, fluvoxamine, mianserin, imipramine) 
Chlorogenic acids – antidiabetic drugs (acarbose) 
↑ Cardiovascular 
functionality 
↓ Inflammatory state 
↑ Psychiatric 
condition 
↓ Glycemic response 
Belayneh and Molla (2020) 
Alongi and Anese (2018)  
Apple juice Phenolic acids – antidiabetic drugs (acarbose) 
Flavonoids – anti-inflammatory drugs (midazolam, 
fexofenadine) 
↓ Glycemic response 
↓ Inflammatory state 
Alongi et al. (2018) 
Khuda et al. (2019)  
Turmeric Curcuminoids – antidepressants (buspirone, 
fluoxetine) 
Curcuminoids – cardiovascular drugs (losartan, 
talinolol, celiprolol, nifedipine, rosuvastatin) 
Curcuminoids – antihystamines (loratadine) 
Curcuminoids – chemotherapics (paclitaxel, docetaxel, 
etoposide, tamoxifen, everolimus, phosphosulindac) 
Curcuminoids – cardiovascular drugs (warfarin, 
clopidogrel) 
Curcuminoids – anti-inflammatory drugs (flurbiprofen, 
paracetamol) 





↓ Inflammatory state 
↓ Cancer cell 
proliferation 
↓ Infections 
Adiwidjaja, McLachlan, and Boddy 
(2017) 
Bahramsoltani, Rahimi, and Farzaei 
(2017)  
Black currant and rowanberry Polyphenols – antidiabetic drugs (acarbose) ↓ Glycemic response Boath et al. (2012) 
Diet: food-food 
interaction 
Apple juice, apple cider Polyphenols – carbohydrates ↓ Glycemic response 
↑ Intestinal 
microbiota activity 
Alongi, Verardo, Gorassini, Sillani, and 
Anese (2020) 
Renard et al. (2017)  
Green tea and milk Polyphenols – lipids, proteins ↓ Cancer cell 
proliferation 
Von Staszewski et al. (2012)  
Extra virgin olive oil Polyphenols – lipids ↓ Oxidative status 
↓ Cancer cell 
proliferation 
Alu’Datt et al. (2014) 
Formulation Short dough biscuits enriched 
with apple pomace 
Polyphenols, dietary fiber ↓ Glycemic response  Alongi, Melchior, and Anese (2019)  
Short dough biscuits enriched 
with spent coffee grounds 
Polyphenols, dietary fiber, indigestible carbohydrates ↓ Glycemic response 
↓ Oxidative status 
Martinez-Saez et al. (2017)  
Cereal bars enriched with 
unripe banana flour 
Resistant starch ↓ Glycemic response Utrilla-Coello, Agama-Acevedo, Osorio- 
Diaz, Reynoso-Camacho, and Bello-Perez 
(2013)  
Bean paste enriched with 
onion skin 
Polyphenols ↓ Glycemic response Sęczyk et al. (2015)  
Bean paste enriched with 
onion skin 
Polyphenols ↑ Protein digestibility 
↑ Phenolic 
bioaccessibility 
Sęczyk et al. (2015)  
Coffee added with milk Polyphenols ↑ Phenolic 
bioaccessibility 
Alongi, Calligaris, and Anese (2019)  
Sunflower oil enriched with 
turmeric extract 
Curcuminoids ↑ Curcuminoid 
bioaccessibility 
Calligaris et al. (2020) 
Processing Apple juice/pasteurization Polyphenols ↓ Glycemic response Alongi et al. (2018)  
Apple juice/ultrasonication Polyphenols ↓ Glycemic response 
↑ Serum transport 
Alongi et al. (2019)  
Blackcurrant juice/enzymatic 
treatment and reverse osmosis 
Anthocyanins, flavonols ↓ Glycemic response 
↓ Oxidative status 
↑ Cardiovascular 
functionality 
Castro-Acosta et al. (2016) 
Pap et al. (2010)  
Coffee/roasting Polyphenols, Maillard reaction products ↓ Glycemic response 
↑ Phenolic 
bioaccessibility 
↓ Oxidative status 
↓ Cancer cell 
proliferation 
Alongi and Anese (2018) 
Budryn et al. (2017)  
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matrices in which such compounds are contained, and the physiological 
functions affected by the interaction. It can be noticed that a plethora of 
physiological functions, mostly related to the onset of chronic non- 
communicable diseases, is influenced by food-drug interactions. How-
ever, most of the studies available in the literature refer to model sys-
tems and especially to bioactive compound extracts (Boath, Stewart, & 
McDougall, 2012; Ni, Hu, Gong, & Zhang, 2020), whereas only few 
examples deal with the whole food matrix (Table 3). This is because 
studying food-drug interaction is hindered by the food matrix 
complexity, which complicates the comprehension of interactions at the 
molecular level (Koziolek et al., 2019). 
As a result, even if the development of improved drug delivery 
technologies is increasing, there is still a lack of understanding of the 
effect of food co-ingestion (O’Shea, Holm, O’Driscoll, & Griffin, 2019). 
In this regard, we recently tried to get an insight into the interaction 
between apple juice, i.e., a whole food matrix, and acarbose, which is a 
drug used to treat type 2 diabetes. Acquired results showed that properly 
combining food with a conventional drug may produce synergies to-
wards α-glucosidase inhibition in vitro, paving the way for drug dose 
reduction and side effects restraint (Alongi, Verardo, Gorassini, & Anese, 
2018). Even so, this is still a very early topic and no authorized in-
structions to modify drug dose depending on the food consumed exist 
yet (Koziolek et al., 2019). 
Besides food-drug interactions, also those among food components 
and between different foods could represent a promising dietary 
approach to be exploited for increasing food functionality. Even so, little 
information is available about the interactions among micronutrients 
and between these and the macronutrients (Alu’datt et al., 2019). 
Moreover, also in this case, only a few studies consider these interactions 
within the actual food matrices, whereas most studies deal with 
simplified systems containing pure compounds (Bungau et al., 2019). 
Nonetheless, food-food interactions have been demonstrated to affect 
several physiological functions. In particular, the few studies available 
on this topic highlighted the crucial role of phenolic compounds towards 
carbohydrate and lipid digestion, indicating that a proper dietary intake 
of these compounds can help to modulate macronutrient bioavailability 
and thus managing related diseases, such as cardiovascular ones and 
type 2 diabetes. In this regard, we demonstrated that administering 
short dough biscuits with apple juice, instead of a soft drink having the 
same sugar composition as the juice, allowed modulating the glycemic 
response (Alongi, Verardo, et al., 2020). This outcome was attributed to 
the bioactive compounds delivered by the juice, such as phenolic ones 
and soluble dietary fiber, which are known to exert an antidiabetic effect 
by inhibiting carbohydrate digestive enzymes and by modifying the 
intestinal transit rate, respectively (Boyer & Liu, 2004; Weickert & 
Pfeiffer, 2018). Similarly, as reviewed by Renard, Watrelot, and Le 
Bourvellec (2017) the intake of apple cider improved the intestinal 
microbiota activity thanks to the presence of proanthocyanidins which 
affect the production of colonic metabolites. Still, the mechanisms 
behind food-food interactions were only partially disclosed and further 
research is required to achieve an understanding deep enough to steer 
dietary interventions towards an effective health benefit. 
2.2.2. Formulation 
From the technological viewpoint, the first step to deliver health 
benefits through food is to modify their formulation in a tailor-made 
manner. Different tactics can be applied to accomplish the targets re-
ported in Table 2. In particular, formulation can be directed to 
removing/replacing certain ingredients or adding bioactive compounds, 
thus obtaining:  
• light food, in which the concentration of an undesired component is 
reduced (e.g., “low fat”, “low sugar”); it derives from the increase in 
the non-caloric fraction or the removal (and replacement) of unde-
sired components (McClements et al., 2015);  
• enriched or fortified food, in which a bioactive compound has been 
added (e.g., prebiotics and probiotics, vitamins A, D, B12, and calcium 
in vegetable beverages) or its presence has been increased (e.g., di-
etary fiber in bakery products, vitamins in fruit juices), respectively; 
these can be obtained by bolstering the delivery of naturally present 
bioactive compounds, by adding them to the product, or by inducing 
their formation upon processing (McClements, 2009);  
• enhanced food, in which the content of a bioactive compound has 
been improved by specific agricultural (e.g., selenium in potatoes), 
genetic (e.g., vitamin A in rice), and breeding (e.g., ω-3 in eggs) 
practices. 
Regarding ingredient removal/replacement, one of the major issues 
concerns the excessive consumption of sugar, which is negatively asso-
ciated with many health outcomes. Several ingredients are currently 
available and applied in the food industry to overcome this issue, such as 
low-calorie carbohydrates (e.g., oligofructose, maltodextrin, and poly-
dextrose), non-nutritive sweeteners (e.g., acesulfame-K, sucralose, 
aspartame), as well as their combination (Luo, Arcot, Gill, Louie, & 
Rangan, 2019). 
In the last years, there has been a growing interest also in fat mi-
metics to reduce caloric intake and/or to modulate lipid digestion (Guo, 
Ye, Bellissimo, Singh, & Rousseau, 2017; Martins, Vicente, Cunha, & 
Cerqueira, 2018). The most promising solutions are represented by 
emulsions and organogels. Besides replacing fat, in recent years these 
ingredients have been under investigation also for their capacity to 
address the second target of formulation interventions, i.e., the delivery 
of bioactive compounds (Mao, Lu, Cui, Miao, & Gao, 2019; McClements 
& Li, 2010). In fact, these structured systems are able to protect lipo-
philic bioactives, such as curcuminoids and carotenoids (Calligaris, 
Alongi, Lucci, & Anese, 2020; Salvia-Trujillo et al., 2017), during the 
gastrointestinal transit and to increase their delivery, which is known to 
be critical otherwise. As reported in Table 3, studies regarding the 
addition of bioactive compounds mainly concern phenolic-rich in-
gredients for the control of the glycemic response, as in the case of 
bakery products formulated with spent coffee grounds, onion skin, and 
apple pomace (Alongi, Melchior, et al., 2019; Martinez-Saez et al., 2017; 
Sęczyk, Swieca, & Gawlik-Dziki, 2015). 
Although several formulation strategies are available to steer food 
functionality, a major hindrance in the implementation of newly 
developed products at the industrial level lies in the lack of knowledge 
about the food matrix complexity (Parada & Aguilera, 2007). In fact, 
most studies do not take into account the interactions among food 
components upon formulation, resulting in the development of func-
tional ingredients that are effective when assessed alone but behave 
unpredictably when used within a food formulation, due to antagonist, 
additive, or synergistic effects among components. In particular, syn-
ergies allow enhancing the bioactive effect (Jacobs, Tapsell, & Temple, 
2011), representing a tool to increase functionality by taking advantage 
of food matrix complexity (Parada & Aguilera, 2007). In this regard, 
McClements et al. (2015) introduced the concept of excipient food, 
namely food that may have no bioactivity itself but boosts the efficacy of 
another bioactive agent. This can be regarded as an indirect approach to 
enrich food with bioactive compounds and has been trialed in 
polyphenol-containing beverages, such as fruit juices (Rodríguez-Roque, 
Rojas-Graü, Elez-Martínez, & Martín-Belloso, 2014), coffee (Alongi, 
Calligaris, et al., 2019), and tea (Lamothe, Azimy, Bazinet, Couillard, & 
Britten, 2014), by adding dairy products as excipient ingredients. 
2.2.3. Processing 
Together with diet and formulation, another key feature affecting 
food functionality is processing. The general belief is that it increases 
macronutrient digestibility and depletes micronutrients, thus reducing 
the overall nutritional value (Prochaska, Nguyen, Donat, & Piekutowski, 
2000) and representing a drawback towards one of the major drivers for 
functional food design, i.e., enhancing micronutrient intake and 
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absorption (Table 2). Although it is well known to substantially affect 
matrix composition and interactions, only a few studies considered the 
effect of conventional and, even more so, unconventional processing on 
food functionality (Fig. 1b and Table 3). Indeed, the processing 
approach towards the prevention of non-communicable diseases de-
serves further investigation. As an example, we observed that roasting 
modified coffee phenolic profile, boosting its antidiabetic potential 
(Alongi & Anese, 2018). Such changes depended on the intensity of the 
applied process, suggesting that processing interventions can concur to 
modulate food functionality in a tailor-made manner, by finely tuning 
their parameters. Similarly, the effect of conventional pasteurization 
was demonstrated to increase the phenolic content and the bioactivity of 
apple juice thanks to the thermal inactivation of polyphenoloxidase 
(Alongi et al., 2018), whereas an unconventional pasteurization process 
based on ultrasounds further increased the phenolic content of apple 
juice, due to the combination of cavitation with heat that promoted the 
release of phenolic compounds from the vegetable matrix (Alongi, 
Verardo, et al., 2019). This evidence confirmed that processing can 
positively affect food functionality, and thus its effects need to be 
thoroughly investigated to understand the reasons behind this influence. 
2.3. Evaluation: After all, does it work? 
Indeed, further research is required to assess the actual impact of 
technological interventions, considering both formulation and process-
ing, as well as the co-ingestion with other food and/or drugs, on the fate 
of bioactive compounds contained in real food matrices. In fact, to 
authorize the commercialization and to claim the bioactivity of func-
tional food, it is necessary first to demonstrate its efficacy (Reg. (EU) n. 
1924/2006). 
Ascertaining the disease prevention capacity of a newly developed 
functional food requires understanding the factors governing the release 
of bioactive compounds from food, the extent of absorption, and their 
fate in the organism, considering all the steps along the journey from the 
food matrix to the target tissue or organ. These include consumption, 
gastrointestinal events, absorption, and distribution (Motilva, Serra, & 
Rubio, 2015), and their key indicators are (Stahl et al., 2002):  
• Bioaccessibility: the fraction of ingested compound released from the 
food matrix and available for intestinal absorption (Ferruzzi, 2010). 
It depends not only on the liberation from the food matrix but also on 
the solubility in the gastrointestinal fluids and on the interactions 
with other constituents in the gastrointestinal tract.  
• Transformation: bioactive compounds may incur chemical (e.g., 
oxidation/reduction, hydrolysis) or biochemical (e.g., enzymatic 
metabolism) transformations within the gastrointestinal tract, which 
may alter their molecular structure (McClements et al., 2015).  
• Absorption: referring to the passage of bioactive compounds across 
the mucus layer, through the epithelium cells, and into the systemic 
circulation, mainly depending on the permeability of the gut wall 
and the transport mechanism (i.e., active, passive, tight junction) 
(McClements et al., 2015; Rein et al., 2012). 
• Biodistribution: that accounts for the temporal and spatial distribu-
tion of the bioactive compounds to different tissue compartments 
after intestinal absorption (Motilva et al., 2015), which mostly de-
pends on their affinity for blood transport proteins. 
• Bioavailability: representing the fraction of ingested bioactive com-
pounds that end up in the systemic circulation reaching the active 
site in an active form (Stahl et al., 2002). 
Evidence can be collected by applying the same approach as that 
used for orally ingested drugs, such as in-vitro mechanistic analyses, 
including simulated digestion and cell culture models, followed by in 
vivo studies, including animal experiments and human clinical trials 
(Fig. 2). However, the behavior of a food matrix is different as compared 
to that of drugs: even if they follow the same metabolic pathway, 
applying the pharmacokinetic concepts to food is challenging. Drugs 
contain one or few pure components targeting a specific action site, 
whereas, as already pointed out (Table 3), food contains a plethora of 
micronutrients potentially interacting one with each other, thus result-
ing in a modified outcome (Motilva et al., 2015). In addition, these 
compounds are present in a complex matrix, mainly consisting of mac-
ronutrients (i.e., carbohydrates, proteins, and lipids), which affects the 
functionality indicators (Parada & Aguilera, 2007). Nonetheless, the 
digestion process and the presence of a complex intestinal microbiota 
can modify the micronutrients, affecting their bioactivity (Rein et al., 
2012). As a result, unraveling the efficacy of functional food is chal-
lenging and pieces of information regarding the effects of food matrix on 
the bioactivity of some nutrients are still conflicting. 
Although in vitro standardized models to simulate digestion are 
available in the pharmaceutical field (United States Pharmacopeia 
methods), they are unsuitable for complex food matrices. As several 
different methods have been applied in the food sector making a com-
parison impossible, the international INFOGEST network harmonized 
the conditions for a static simulation of food digestion (Brodkorb et al., 
2019; Minekus et al., 2014) and more recently a semi-dynamic 
Fig. 2. Methodologies that can be applied to assess food functionality and relevant indicators.  
M. Alongi and M. Anese                                                                                                                                                                                                                       
Journal of Functional Foods 81 (2021) 104466
7
standardized method has also been proposed (Mulet-Cabero et al., 
2020). Indeed, the increase in precision and reproducibility guaranteed 
by standardized methods makes them a useful tool for sample screening, 
to get indications relevant to bioaccessibility and transformation. 
In some cases, cell culture models (e.g., Caco-2 cell line) are used 
after digestion simulation (Fig. 2) to investigate the mechanism and 
extent of absorption of bioactive components from food (Hur, Lim, 
Decker, & McClements, 2011), as well as to study the metabolic re-
actions occurring in the gut lumen or within the enterocyte, and leading 
to compound transformation (Konishi & Kobayashi, 2004). 
After the preliminary in vitro screening, it is necessary to switch to in 
vivo models to understand the actual physiological response to specific 
foods, including information regarding biodistribution and bioavail-
ability (Fig. 2). Animal models are generally applied first. However, 
although they allow getting close to physiological human conditions, 
they have been questioned both in reliability and ethical terms (Brod-
korb et al., 2019). In addition, in vitro and animal experiments are only 
accepted as supporting data, whereas human clinical trials are 
compulsorily required (Reg. (EU) n. 353/2008) for the authorization of 
a health claim. 
Even if human interventions represent the gold standard, they bring 
about further management and ethical issues (Brodkorb et al., 2019). 
Furthermore, both animal and human trials can only provide indications 
about the functional efficacy but do not give insights into the mechanism 
underlying it. They can thus only represent the final validation step 
(Dupont et al., 2018), while it is essential to get as much information as 
possible from the in vitro screening. In fact, details about the molecules 
carrying bioactivity and the mechanism behind it are essential to steer 
technological interventions towards functionality (Rein et al., 2012). In 
other words, in vitro trials represent a crucial tool to pre-qualify the 
technological interventions most promising in boosting food function-
ality before in vivo validation. 
Once the functionality indicators have been assessed, the last key 
step to assess food functionality is measuring the targeted bioactivity, 
which represents the physiological effect carried out by a bioactive 
compound once it has reached its active site (Stahl et al., 2002). Both in 
vitro and in vivo trials are carried out to get an output that can be related 
to the physiological effect of the ingested functional food. Food func-
tionality has been generally attributed to bioactive compounds having 
antioxidant, anticarcinogenic, and antidiabetic capacities. These prop-
erties can be tested by applying several techniques, most of which are 
based on in vitro tests. As already pointed out, these are easy, cheap, and 
fast. However, they do not consider the complexity of biochemical 
conditions occurring in the human body. In fact, for most bioactive 
compounds the metabolic pathway has not been fully characterized yet. 
This represents an essential step to understand which are the compounds 
responsible for the functionality of food and in which form they carry 
out the health-promoting effect (Rein et al., 2012). In addition, in vitro 
testing represents a simplification and does not take into account the 
actual physiological response. It is, therefore, crucial to measure the 
biological activity in vivo, by monitoring the parameters of interest 
relevant to a specific disease, through direct and dynamic measurements 
(Heaney, 2001). For instance, the antidiabetic efficacy can be assessed 
by measuring the glycemic response during the time after food con-
sumption (Wolever, Jenkins, Jenkins, & Josse, 1991). Similarly, tri-
glyceride blood levels are informative about interventions aimed at 
reducing lipid absorption (Tan, Wan-Yi Peh, Marangoni, & Henry, 
2017). Still these tests are not revealing about the mechanisms under-
lying the observed effect. 
Due to the need to understand both the efficacy under physiological 
conditions as well as the mechanism behind food functionality, there is 
an increasing interest in converging disciplines dealing with monitoring, 
modeling, and analysis of complex biological systems. The development 
of wearable devices, which has started in early 2000, has actually 
experienced a steep increase in the last 5 years, accounting for more than 
5,000 published patent applications (Mück, Ünal, Butt, & Yetisen, 
2019). Wearable devices, including smartwatches (e.g., Apple Watch), 
glasses (e.g., Google Glass), fitness bands (e.g., FitBit), connected apparel 
(e.g., Sensoria), are becoming particularly popular to monitor continu-
ously the health status (Piwek, Ellis, Andrews, & Joinson, 2016). The 
presence of biosensors embedded in electronic tattoos, patches, pros-
thetics, textiles, wristbands, and contact lenses give direct access to 
personal analytics, including physical activity and posture, calorific 
expenditure, skin/core temperature, heart rate, respiratory parameters, 
oxygen consumption, electrocardiography (ECG), and sleep duration 
and quality (Yetisen, Martinez-Hurtado, Ünal, Khademhosseini, & Butt, 
2018). This information can facilitate preventive care and aid in the 
management of non-communicable diseases. For chronic food-related 
diseases, wearables could be applied as a novel tool to assess food 
functionality in vivo through real-time detailed data (Piwek et al., 2016). 
In particular, some of these systems can be inserted in the oral cavity to 
measure food intake for controlling the eating behavior and provide data 
directly related to chronic diseases (Lee et al., 2018). In this way, patient 
progress could be monitored to assess the efficacy of applied in-
terventions, which in turn can be personalized, thanks to the emerging 
scientific field of nutrigenomics (German, Zivkovic, Dallas, & Smilowitz, 
2011). Indeed, when dealing with functional food development, 
personalized nutrition is hardly achievable in the narrower sense, i.e., 
counting on individual characteristics to produce a dedicated output, as 
the cycle could not be applied to single cases. However, personalized 
nutrition can also be referred to the delivery of products to consumer 
categories having specific dietary requirements (Chaudharya et al., 
2021). 
In this terms, personalized nutrition could be exploited to categorize 
the population based on individual requirements, thus identifying con-
sumer clusters to be addressed while developing functional foods. 
Although several studies have attempted automating dietary moni-
toring using wearable devices, several issues remain opened (Prioleau, 
Ii, Member, & Paper, 2017). Few studies are available on the reliability 
of acquired data, as the major hindrance lies in the interference of sig-
nals. In addition, the output interpretation depends on the under-
standing of the analyzed biological system, requiring a deep knowledge 
of the mechanisms underlying targeted functionality. 
2.4. Market delivery: Last but not least, the consumer response 
The successful delivery of a newly developed functional food on the 
market is affected not only by the carried health benefit but strictly 
depends on several other factors. Besides the typical quality markers (e. 
g., taste, convenience, price), these include market positioning and 
functionality communication (Kaur & Das, 2011). 
Settling the most effective communication strategy should consider 
many determinants affecting the decision to accept or reject a new food 
(Giordano, Clodoveo, De Gennaro, & Corbo, 2018). 
These include not only the product features, but also and most 
importantly the individual characteristics. 
Product features represent primary factors leading consumption 
decisions and can be distinguished into intrinsic, e.g., presence of health- 
promoting compounds, and extrinsic attributes, e.g., package, brand, 
label claims (Bimbo et al., 2017). As product development is mostly 
focused on the intrinsic ones, a mismatch between the functional food 
features and consumer expectations may thus occur (Van Kleef, Van 
Trijp, & Luning, 2005), bringing about a high risk of product failure 
(Research and Markets, 2015). In fact, also the extrinsic attributes, 
among which labelled information, and especially nutritional and health 
claims, is the most crucial, may substantially contribute to the success of 
new functional food (Siegrist, Stampfli, & Kastenholz, 2008). However, 
these are often formulated in complicated terms, being less effective, as 
consumers cannot recognize the benefits nor their importance (Siegrist 
et al., 2008). 
Individual characteristics represent another group of primary factors 
driving consumption intention. These are represented not only by 
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demographic characteristics, such as gender and age, but when dealing 
with functional food include the knowledge about the health-diet rela-
tionship and the interest for maintaining a health status. In this regard, 
only a niche of the targeted consumer is aware of health-related benefits, 
making necessary further efforts to also reach the other consumers 
(Giordano et al., 2018). The psychological factors must also be included 
among individual characteristics. In fact, the consumption intention is 
based on two coexisting and opposite tendencies: the curiosity about 
novelty, called neophilia, and the prudence towards new and potentially 
dangerous products, namely neophobia (Fischler, 1988). Communication 
should thus find the optimal strategy to induce curiosity while pre-
venting fear (Giordano et al., 2018), keeping an eye not only on the 
rational aspects, but also on the emotional perspective. 
Pushing consumption intention becomes even more complicated 
when the primary factors must be matched with the secondary ones. 
These include risk perception, subjective norms, and cost/benefit 
balance. 
A deep knowledge of the factors determining consumption decision 
is crucial to successfully drive the development of new products. To this 
purpose, consumer research must be applied by means of different tools 
(Van Kleef et al., 2005). These include qualitative methods (e.g., focus 
group), which are indicated during the definition of labeled information, 
and quantitative ones (e.g., conjoint analysis), suited to test the efficacy 
of claims (Van Kleef et al., 2005). 
Although the availability of many tools, the literature reports con-
tradictory results. According to some authors (Bimbo et al., 2017; Van 
Kleef et al., 2005), consumers prefer specific health claims, dealing with 
the prevention or risk reduction of a disease (e.g., heart failure) more 
than general nutritional ones dealing with wellbeing (e.g., energy- 
boosting). On the contrary, Schnettler et al. (2019) found consumers 
to be more interested in generic nutritional labeling (e.g., source of 
fiber). Contradictory results may depend on the different decision pat-
terns applied to different product categories (Bimbo et al., 2017), 
suggesting the need for a tailor-made product assessment. This would 
provide an essential tool to implement an approach to innovation that is 
not just product-driven but consumer-oriented instead (Van Kleef et al., 
2005). In fact, consumers are currently only involved in the prototyping 
and launching phases, but they could potentially play a crucial role in 
the previous ones, namely idea generation and concept design (Busse & 
Siebert, 2018). 
3. The “functional food development cycle” 
Like other innovation systems, functional food development is a non- 
linear, multiple-actor process (Freeman, 1987). It involves several 
stakeholders, including food technologists, nutritionists, clinicians, 
marketing experts, as well as consumers, with different interests, per-
spectives, and skills that can hardly be matched. An attempt to provide a 
multidisciplinary tool for food design was presented by Sijtsema, 
Fogliano, and Hageman (2020), i.e., the Circular Food Design. Such an 
approach is particularly focused on consumer, pointing out the impor-
tance of her/his involvement at all stages of food design from oppor-
tunity identification to market delivery. 
Besides consumers, also the other actors taking part to functional 
food development should be directly or indirectly involved in all the 
required steps. Yet, merging all these different viewpoints probably 
represents the hardest task for manufacturers dealing with functional 
food development (Moors, 2012). Still, an integrated outcome is 
essential to successfully deliver a new functional food on the market. 
This principle actually lays the foundation for the circular and iterative 
approach here proposed as the “Functional Food Development Cycle”, 
consisting of sequential and interconnected steps (Fig. 3). 
The preliminary step is called definition and implies selecting the 
disease to be addressed by the functional food, as well as choosing the 
most suitable food matrix and bioactive ingredient. As highlighted by 
Sijtsema et al. (2020), already during opportunity identification the 
Fig. 3. Functional Food Development Cycle.  
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consumer must be involved. When dealing with the definition step of 
functional food development it is thus necessary to have clear in mind 
the group of consumers to be targeted and their requirements, paying 
attention to perceptions, barriers, needs and wishes. 
All these activities should fit in a regulatory framework, including 
functional food definition, delineated by the legislator, which outlines 
and implements policies to influence the innovation process and guar-
antee the operability of the functional food market (Moors, 2012). To lay 
down definitions and rules for health claims, the legislator collects 
technical information from food technologists, clinicians, and nutri-
tionists. Besides a general univocal definition of functional food is 
required, also more specific operative definitions could be descended 
from it, based on stakeholder requirements and taking into account the 
perspective of each involved discipline, to make clear and usable the 
concept for all the actors involved, ultimately making functional food 
development effective. 
Once the target is known, it is possible to manage the second step, i. 
e., functional food design. This represents the technological core of 
functional food development and requires selecting the most appro-
priate intervention, including dietary approaches, as well as processing 
and formulation. Food technologists play a crucial role in functional 
food design due to their technical skills, i.e., knowledge of food matrix 
and technological interventions (Bigliardi & Galati, 2013; Granato, 
Nunes, & Barba, 2017). During functional food design, not only the 
targeted disease but also the targeted consumer group and its re-
quirements, including the sensory ones but also habits and preferences, 
must be taken into account to develop successful products (Sijtsema 
et al., 2020). 
The third step, i.e., evaluation, is then crucial to assess the efficacy of 
technological interventions towards functionality, while guaranteeing 
the accomplishment of quality requirements, which are assessed by the 
food technologist. On the other hand, the efficacy evaluation is 
commonly a task of clinicians and nutritionists, particularly when 
dealing with in vivo trials (Granato et al., 2017). 
Indeed, product design that is carried out by food technologists, and 
efficacy evaluation, which relies on the activity of nutritionists and 
clinicians, represent the key technological steps in functional food 
development and merging them is essential. However, this is not 
straightforward as it is difficult to find a common language among the 
actors involved. In fact, when the technological viewpoint prevails, the 
physiological effect (i.e., digestion) is barely considered, and the tar-
geted bioactivity is evaluated considering the undigested food matrix. 
Conversely, when the nutritional viewpoint prevails, the effect of 
digestion on bioactive compounds is assessed mostly on simplified 
model systems, thus not considering the technological history of food. 
This approach seems disjoint as it does not consider the complexity of 
the food matrix, the potential interactions occurring among food com-
ponents, the effect of technological interventions, nor the actual bioac-
tivity upon digestion, resulting in a gap between the technological and 
the nutritional viewpoints. Indeed, such a compartmentalized approach 
leads to misinterpretations. For instance, dealing with apple juice 
pasteurization, we observed a significant increase in the phenolic con-
tent when an unconventional process (i.e., ultrasound-assisted) was 
applied instead of the conventional (i.e., thermal) one. Even so, when 
digestion was simulated, differences induced by the technological 
intervention were flattened (Alongi, Verardo, et al., 2019). Analogous 
results were obtained in the case of coffee roasted to different intensities 
(Alongi, Frías Celayeta, et al., 2020). To bridge the gap between the 
technological and the nutritional viewpoints, an integrated approach to 
design and evaluate functional food should be considered (Fig. 4). Based 
on this approach, the effect of technological interventions, including 
dietary approaches, formulation and processing, should first be assessed 
in terms of safety and quality (i.e., physical, chemical, and sensory 
properties). Technological interventions should be carried out to 
concomitantly boost food functionality while maintaining or improving 
product quality, as consumers are not willing to compromise the taste on 
behalf of health benefits (Lähteenmäki, 2013). Once quality re-
quirements are satisfied, the impact on functionality should be assessed. 
Merging these outcomes in a process optimization perspective is then 
pivotal to develop effective functional foods. 
Nonetheless, market delivery is essential for the success of the newly 
developed functional food, and requires a fourth step, in which con-
sumer education and labelled information play a pivotal role. To this 
purpose, the marketing expert collects information on consumer attitude 
and acceptability towards functional foods through marketing surveys. 
This information should be merged with social and cultural aspects by 
an anthropological approach, with special attention to food neophilia 
and neophobia (Van Kleef et al., 2005). Although during this step con-
sumers mainly represent the observation subject (Van Kleef et al., 2005), 
communication strategies should be optimized, and besides accom-
plishing claim regulation (Siró et al., 2008), should help collecting in-
formation about consumer needs. This would represent an input for 
regulatory bodies to selectively drive the development of functional food 
within a virtuous cycle, including a deeper involvement of consumers in 
functional food development to lead the innovation process through a 
consumer need-driven approach (Busse & Siebert, 2018). 
Being the approach here proposed (Fig. 3) an iterative cycle, con-
sumer inputs (i.e., requirements) drive consumer outputs (i.e., attitude). 
In other words, the consumer requirements that are considered during 
definition and design are deduced from the output of market delivery, i. 
e., consumer attitude. The latter in turn results from the consumer re-
action to a functional food deriving from the previous cycle round, 
which has been developed based on previously outlined requirements, 
as in subsequent upward turns of a spiral. 
Indeed, being functional food consumption associated with health- 
related benefits, also clinicians, together with nutritionists, are key ac-
tors dealing with consumers (Bigliardi & Galati, 2013). Besides defining 
nutritional needs, they should clearly outline to consumers the benefits 
deriving from the consumption of functional food, ultimately driving 
consumer choices. 
As outlined by describing each step, functional food development 
requires a collaborative cross-network among stakeholders at all stages 
(Busse & Siebert, 2018). In light of this, functional food development 
cannot be referred to as a linear process starting from definition, going 
through design and evaluation, finally ending with market delivery. On 
the contrary, a circular approach, considering during all steps the 
contribution and the viewpoints from the other ones back and forward 
Fig. 4. Insight into the integrated approach to the key technological steps, i.e., 
design and evaluation, of the Functional Food Development Cycle. 
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becomes crucial, particularly when dealing with health. 
To this purpose, dissemination is a cross-cutting activity essential to 
merge each step of the cycle, thus guaranteeing its effective functioning 
(Fig. 3). In fact, dissemination represents the process of making avail-
able knowledge to stakeholders and the widest audience and can be 
therefore decoupled into two aspects. First, it is intended as informing 
and educating the public about the functional food issue. Overall, con-
sumers demonstrate a high awareness, but a low level of actual knowl-
edge, leading to high levels of concern that hinders the acceptance of 
functional foods especially when obtained by applying emerging tech-
nologies (Giordano et al., 2018). Educating consumers is crucial to in-
crease the actual knowledge about newly developed functional food and 
the benefits associated with their consumption (Bech-Larsen & Schol-
derer, 2007). In fact, it is essential to carry out dedicated actions 
because, unlike sensory traits, consumers cannot directly perceive the 
benefits of the product (Siró et al., 2008). These actions may include 
educational activities in the schools, awareness-raising campaigns in 
public places, but could also take advantage of labeled information 
(Lähteenmäki, 2013). This should be intelligible by the average con-
sumers, making them correctly understanding the information behind 
claims. The other dissemination task consists of raising stakeholder 
awareness. It relies on the exchange of information about the ongoing 
research and current development in the functional food field among 
professionals, such as scientists and researchers, health professionals, 
nutritionists, food technologists, and marketing experts (Gur et al., 
2018). Dissemination can be carried out in conventional ways, such as 
conferences, workshops, and scientific publications, but also through 
emerging channels, including the social network (Cooper, 2014). The 
required effort is to find a common language among the experts involved 
in the cycle, to draw an exhaustive picture of the state of the art, and to 
identify the most effective strategy to be followed for functional food 
development. To do this, it is crucial to identify the factors influencing 
the communication among the actors involved in the development of 
new products. Generally, industries mostly focus on the internal 
communication between marketing and technology functions, but 
Jacobsen et al. (2014) highlighted the importance of filling the 
communication gap with external partners as well. In the context of 
functional food development, these include the legislator, nutritionists 
and clinicians, as well as the consumer. 
Besides being an object of dissemination, during market delivery, the 
consumer can also play an active role in that. In fact, even though 
generally consumers are only involved in the prototyping and launching 
phases, they could potentially play a crucial role in the idea generation 
and concept design (Busse & Siebert, 2018). Indeed, a deeper involve-
ment of consumers in functional food development would help the other 
stakeholders in developing customized and effective communication 
strategies. 
4. Healthy and sustainable: The future of “functionable” food 
During the last years, the need to redefine the boundaries of food 
production has come to light. We are currently dealing with major and 
opposite issues. On one hand, the exponential increase in worldwide 
population is posing at risk food security (Godfray et al., 2010). On the 
other hand, we are facing a dramatic increase in non-communicable 
diseases, caused by excessive food intake or unbalanced diets (WHO, 
2014). To handle these trends, it is necessary to look in a more inte-
grated way at the current food production (De Vries, Axelos, Sarni- 
Manchado, & O’Donohue, 2018). In other words, it is necessary to 
think in terms of food system. This is defined as a framework considering 
all the elements (i.e., environment, people, inputs, outputs, processes, 
infrastructures, institutions) and activities related to primary produc-
tion, processing, distribution, preparation, and consumption of food, 
also considering the socio-economic and environmental outcomes of 
these activities (Perrot et al., 2016). Thus, developing healthy products 
requires food product design to operate within environmental and 
health-related boundaries, to deliver on the market healthy and at the 
same time sustainable food (Willett et al., 2019). 
To this purpose, it is essential to establish some limits. First, avoiding 
the unnecessary exploitation of resources, which is possible by applying 
different strategies, including consuming low density-high satiating 
food, and replacing traditional protein sources (i.e., dairy products, 
conventional meat, eggs) with more sustainable ones, including vege-
tables, e.g., legumes and algae (Bessada, Barreira, & Oliveira, 2019; 
Bleakley & Hayes, 2017), fungi, e.g., Quorn® (Schweiggert-Weisz, Eis-
ner, Bader-Mittermaier, & Osen, 2020) and animal sources, e.g., insects 
and cultivated meat (Baiano, 2020; Tomiyama et al., 2020). Second, 
efficiently transform and use resources, that is feasible through targeted 
and eco-efficient processes. Lastly, valorizing processing discards, by 
applying the food waste pyramid (Manzocco, Alongi, Sillani, & Nicoli, 
2016; Plazzotta, Manzocco, & Nicoli, 2017). 
In other words, the functional food development cycle here proposed 
needs be framed in a wider background looking at its overall feasibility, 
which includes evaluating its sustainability (Fig. 3). Such an approach is 
in line with the Agenda 2030 of the European Union, in which the 
Sustainable Development Goals, and in particular the “Good health and 
well-being” and the “Zero hunger” goals, highlight the importance of a 
sustainable diet not only from a nutritional viewpoint but also for planet 
health (European Commission, 2019). Indeed, these requirements 
should match also economic objectives. These were recently demon-
strated to be possibly maximized concomitantly with the environmental 
ones, by applying innovative valorization strategies such as the pro-
duction of a functional flour from lettuce waste (Plazzotta, Cottes, 
Simeoni, & Manzocco, 2020). Ultimately, research urgently needs to 
focus on the application of conventional and unconventional processes, 
and on the exploitation of processing wastes as bioactive ingredients to 
increase the environmental and economic sustainability of food pro-
duction, while enhancing its functionality (Van Der Goot et al., 2016), to 
obtain what can be called a “functionable” food. 
5. Research on “functionable” food: what’s next? 
Based on previous considerations, moving a step forward into 
implementing the functional food development cycle through a holistic 
approach appears crucial. Accomplishing this comprehensive aim re-
quires pursuing specific ones, such as:  
• Filling the gap between the key technological steps of functional food 
development, i.e., design and functionality evaluation: merging these 
viewpoints, concomitantly considering the technological history of a 
food product and the changes induced by the physiological mecha-
nisms upon its ingestion, is essential to avoid result misinterpretation 
and represents the foundation on which strong and reliable knowl-
edge about food functionality can be built.  
• Studying the complex matrix instead of bioactive extracts: exploring 
the functional properties of the whole food leads to different results 
as compared to those available in the literature on simplified model 
systems that generally consider bioactive compound extracts. The 
whole matrix plays a crucial role due to interactions occurring 
among the different components.  
• Identifying bioactivity indicators, understanding the mechanisms 
behind functionality, and defining the targeted bioactivity: in-
dicators of food functionality should be considered in the light of 
overall available data to prevent misinterpretation. For instance, the 
bioaccessibility of a bioactive compound is often regarded as the 
main indicator, but it provides only partial information. On the 
contrary, identifying its mechanism and defining the desired con-
centration at the intestinal level, as well as in the target organs and 
tissues, would help develop the proper technological intervention to 
drive functionality through food design by a customized approach.  
• Understanding the mechanisms underlying food-drug interactions: 
in a real-life setting, patients take oral drugs with food. However, no 
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detailed information about the interactions occurring between food 
and drug is available, nor the knowledge of the mechanisms behind 
it. Indeed, pharmacodynamics and pharmacokinetic data regarding 
food-drug interactions could pave the way for adjusting drug dosage 
accordingly to the co-ingested food, possibly exploiting the bioac-
tivity of compounds contained in functional food.  
• Increasing the sustainability of functional food development, by 
using vegetable processing wastes, as well as alternatives to tradi-
tional protein sources, as innovative functional ingredients. 
• Investigating consumer attitude towards the consumption of func-
tional food formulated with vegetable processing waste: marketing 
and anthropological methodologies should be applied to define the 
most effective strategies to drive consumer choices. 
6. Implications of “functionable” food: what’s beyond? 
Once the functional food development cycle has been implemented 
within the new boundaries in which the food system is required to 
operate, “functionable” food, able to prevent specific diseases while 
increasing the sustainability of food production, will be obtained. Be-
sides the direct outcome, several impacts are expected in different fields, 
by affecting all the stakeholders involved in “functionable” food devel-
opment and consumption: 
• Research and education: improving the knowledge about the inter-
connection among food properties, biological functions, sustain-
ability, and consumer perception will increase the awareness of the 
importance of producing and consuming functional food that is also 
sustainable. Understanding the interplay among food design, func-
tionality, and sustainability will increase scientific knowledge 
regarding the formulation and processing of functional and 
concomitantly sustainable food. Studying consumer behavior and 
attitude will help to develop adequate strategies to communicate 
product innovation correctly and effectively, through health and 
sustainability claims, facilitating consumers to select food that fits 
into a healthy and sustainable diet. 
• Economics: optimizing functional food development will incite pro-
ducers to manufacture high-quality, healthier, and sustainable food 
that fulfills consumer and market expectations, increasing the 
innovative potential and competitiveness of the food industry. In 
addition, the opportunity to valorize industrial waste as a functional 
ingredient will help reducing waste management costs while 
benefiting from the generation of value-added output, representing 
an always available, cheap, and bioactive-compound-rich ingredient. 
• Public health: once food functionality has been improved, consid-
ering its consumption in a real-life setting and bearing in mind the 
eventual food-drug interactions, health workers will be advocated to 
promote among patients healthy eating habits as the first tool to face 
non-communicable chronic diseases. This will not only improve 
population wellbeing but also reduce the healthcare costs required to 
manage non-communicable chronic diseases, by reducing the need 
for pharmacological interventions. This approach should be favored 
by a revision and an update of the current health and food policies, 
possibly implementing a dedicated regulatory framework for func-
tional food.  
• Environment: promoting the valorization of industrial waste will 
reduce the amount of food wasted upon industrial processes. The 
current waste management routes should be redefined by integrating 
waste valorization strategies, e.g., implementing an industrial park- 
oriented view approach to minimize waste transport. Also in this 
case, the policy regarding waste treatment and disposal should be 
revised and updated, by implementing a dedicated regulatory 
framework for the reuse of discards as functional ingredients. On the 
other hand, the use of alternative protein sources would reduce the 
environmental impact associated with the consumption of 
conventional protein sources, such as the threaten to biodiversity, 
the excessive soil exploitation, and the production of greenhouse 
gases. 
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